PatientsVille.com Logo

DRY MOUTH and Viagra

PatientsVille

DRY MOUTH Symptoms and Causes

Dry mouth is the feeling that there is not enough saliva in your mouth. Everyone has a dry mouth once in a while - if they are nervous, upset or under stress. But if you have a dry mouth all or most of the time, it can be uncomfortable and can lead to serious health problems.

Symptoms of dry mouth include

  • A sticky, dry feeling in the mouth
  • Trouble chewing, swallowing, tasting, or speaking
  • A burning feeling in the mouth
  • A dry feeling in the throat
  • Cracked lips
  • A dry, rough tongue
  • Mouth sores
  • An infection in the mouth

Dry mouth is not a normal part of aging. Causes include some medicines, radiation therapy, chemotherapy, and nerve damage. Salivary gland diseases, Sjogren's syndrome, HIV/AIDS, and diabetes can also cause dry mouth. Treatment depends on the cause. Things you can do include sipping water, avoiding drinks with caffeine, tobacco, and alcohol, and chewing sugarless gum or sucking on sugarless hard candy.

NIH: National Institute of Dental and Craniofacial Research

Check out the latest treatments for DRY MOUTH

DRY MOUTH treatment research studies

Viagra clinical trials, surveys and public health registries


Find Drug Side Effect reports



Viagra Side Effects

Headache (505)
Erection Increased (390)
Flushing (324)
Optic Ischaemic Neuropathy (314)
Erectile Dysfunction (300)
Vision Blurred (278)
Hypertension (219)
Dizziness (211)
Prostate Cancer (194)
Visual Acuity Reduced (189)
Nasal Congestion (184)
Incorrect Dose Administered (178)
Blood Cholesterol Increased (173)
Penis Disorder (172)
Death (168)
Myocardial Infarction (165)
Cyanopsia (160)
Dyspnoea (145)
Feeling Abnormal (141)
Cerebrovascular Accident (134)
Blood Pressure Increased (95)
Chest Pain (93)
Visual Field Defect (92)
Diabetes Mellitus (92)
Malaise (83)
Nausea (80)
Pain (78)
Penile Pain (77)
Cataract (75)
Loss Of Consciousness (73)
Heart Rate Increased (72)
Depression (71)
Tinnitus (70)
Condition Aggravated (69)
Off Label Use (68)
Feeling Hot (68)
Visual Impairment (67)
Abdominal Discomfort (66)
Anxiety (66)
Visual Disturbance (65)
Erythema (64)
Dyspepsia (64)
Fall (62)
Ejaculation Disorder (60)
Fatigue (60)
Coronary Artery Occlusion (58)
Weight Decreased (54)
Deafness (54)
Blood Testosterone Decreased (53)
Hypotension (53)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Blepharospasm.

Dizzy, Unstable walking, confused, dry mouth, wake up 3 AM. some slurred speech, tremers, falling, craving sweets, tired.

I have been dehydrated since 11-09 had blood work done only showed low Vitamin D, was hospitalized in 11-09 for bactirial infection in my stomach. Unsteady. confused, dry mouth, some slurred speech, tired, I have had several bags of fluid at doctors

I have been put on Molipaxin 3 weeks ago, I have dry mouth, hair loss and my panic attacks were showing no signs of improvement. Dr increased it to 100mg and put me onto Lamictin. I am not bi polar nor epileptic. My disorder ist algora phoebia. I a

I am taking 2 asacol three times a day and is very difficult sleep and my mouth is dry all the time.

I have experienced panic attacks, light headedness and pasty mouth taking this drug at 400mg's.

<b>Describe Your Zopiclone Experience Here:</b>Dry mouth. Cant sleep without them now

Have been on champix goin on 3 weeks,,have experienced foul taste in mouth,,crazy dreams,,IBS..Starting new business so the stomach issues could be nerves..I have not experienced any weird mood swings,,,The need to have a smoke is almost g

after taking my medicine .i felt abnormal taste in mouth and my bilurubin level was increased.

<span style='color: #808080;'><strong>I have an 11 yr old yorkie that has been on Clavamox 375 mgm for several cycles since end of April. He is also on FlortiFLora to avoid colon distress. His mouth infection has not g

Bad taste in my mouth, very bloated and abdominal pain and reflux

10 mg by mouth daily

2 months so far, diarrhea first few weeks but not so much now. However, some stomach problems, feels like I just ate a 5 course meal some of the time. This morning noticed blood stains on pillow and taste of blood in mouth, bro

DRY MOUTH Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery?
Condition: Pulmonary Hypertension
Interventions: Drug: Sildenafil (Viagra);   Drug: Sildenafil;   Drug: Placebo
Outcome Measures: To determine the efficacy of 12.5mg oral sildenafil to decrease the mPAP in patients presenting with a mPAP >/= 25mmHg after cardiopulmonary bypass.;   To determine the efficacy of a second dose of oral sildenafil 12.5mg to decrease the mPAP in those patients who do not respond with a 20% decrease in mPAP after the initial administration of study medication.;   To determine the safety of oral sildenafil to treat increased mPAP after cardiac surgery.
2 Unknown  Sildenafil for Prevention of Cerebral Vasospasm
Conditions: Subarachnoid Hemorrhage;   Cerebral Vasospasm;   Rupture of Intracranial Aneurysm
Interventions: Drug: Placebo;   Drug: Sildenafil Citrate, 25 mg, 3 times a day.;   Drug: Sildenafil Citrate 50 mg, 3 times a day
Outcome Measures: New neurological Deficit;   Transcranial Ecodoppler;   Mortality;   Side effects;   Time to discharge;   Rankin Scale
3 Unknown  A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies
Condition: Erectile Dysfunction
Interventions: Drug: Sildenafil Citrate 20mg Tablet Sublingual;   Drug: Viagra ® 50mg tablet Coated
Outcome Measures: Evaluate a possible superiority expressed by the faster onset of action.;   Evaluate the efficacy and tolerability of Sildenafil Citrate 20mg Sublingual tablet, compared to Viagra ® 50mg tablet Coated in control of Erectile Dysfunction.
4 Recruiting Pharmacokinetics of Sildenafil in Premature Infants
Condition: Persistent Pulmonary Hypertension of the Newborn
Intervention: Drug: 1 dose of sildenafil
Outcome Measures: Area under the plasma concentration versus time curve 0-24 hours for sildenafil;   Peak plasma concentration of sildenafil;   Clearance of sildenafil;   Volume of distribution at steady state;   Half life of sildenafil;   Number of subjects with adverse events as a measure of safety and tolerability.;   Correlation between serum and dried blood spot samples;   Evaluate P450 single nucleotide polymorphisms (SNPs)
5 Unknown  Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients With CFS
Condition: Chronic Fatigue Syndrome
Interventions: Drug: Sildenafil (Viagra);   Drug: Placebo
Outcome Measure: The principal aim of this study is to determine whether chronic fatigue syndrome (CFS) is due to inadequate blood flow to the brain and to test a medication, Viagra, which should help increase blood flow to the brain and improve the symptoms of CFS.
6 Unknown  Effects of Viagra on Heart Function in Patients With Heart Failure
Conditions: Heart Failure;   Left Ventricular Dysfunction
Intervention: Drug: sildenafil
Outcome Measures: The primary outcome measure is a fall in the left ventricular filling pressure in association with administration of sildenafil;   A secondary outcome is the distance walked with the 6-minute walk test after the administration of sildenafil
7 Not yet recruiting Effects of Oral Sildenafil on Mortality in Adults With PAH
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: sildenafil citrate
Outcome Measures: Overall Survival (OS);   Time to first clinical worsening (TTCW) event;   6 Minute Walk Distance (6MWD) at Months 6 & 12
8 Recruiting VasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary Hypertension
Condition: Pulmonary Hypertension Associated With Connective Tissue Disease
Intervention: Drug: Sildenafil
Outcome Measures: efficacy of Sildenafil I.V. for vasoreactivity testing;   clinical efficacy of sildenafil per os predicted by testing it intravenously in the course of oral therapy
9 Unknown  Early Start of Oral Sildenafil 100mg for Erectile Dysfunction After Robotic Assisted Laparoscopic Radical Prostatectomy
Condition: Prostate Cancer
Intervention: Drug: sildenafil 100mg
Outcome Measures: patterns of recovery of erectile functions after nerve sparing RALP in men with on- demand sildenafil 100mg dosing from the early postoperative period (using IIEF-5);   comparison of the potency rates in men with on- demand sildenafil 100mg dosing from the early postoperative period with from the delayed postoperative period
10 Unknown  Evaluation of Sildenafil for the Treatment of Moderate Congestive Heart Failure
Condition: Heart Failure
Intervention: Drug: Sildenafil
Outcome Measures: Change in 6-minute walk distance;   Changes in peak oxygen consumption (measured by cardiopulmonary exercise testing);   Change in the level of neurohormones (b-type natriuretic peptide, catecholamines, ET-1),;   Change in quality of life
11 Unknown  The Effects of Sildenafil on Exercise Function and Capacity in Patients With Fontan Circulation
Condition: Fontan Circulation
Interventions: Drug: sildenafil;   Other: placebo
Outcome Measure: An increase in exercise capacity for patients administered sildenafil
12 Recruiting The Revaki-001. A Study to Determine the Pharmacokinetic Profile, Safety and Tolerability of Sildenafil (REVATIO®) in Cardiac Surgery
Condition: Acute Kidney Injury
Intervention: Drug: Sildenafil
Outcome Measures: Area under the plasma concentration versus time curve and Plasma Concentration of Sildenafil;   Serum creatinine and Biochemical markers of AKI
13 Recruiting Effects of Sildenafil on Choroidal Thickness in AMD
Condition: Age-related Macular Degeneration
Intervention: Drug: Sildenafil citrate
Outcome Measures: Change in Choroidal Thickness as Assessed on Enhanced-Depth Imaging Optical Coherence Tomography (EDI-OCT);   Change in Central Foveal Thickness as assessed by optical coherence tomography (OCT)
14 Unknown  Viagra for the Treatment of IUGR
Condition: IUGR
Intervention: Drug: Viagra administration in IUGR/PET pregnancies
Outcome Measures: Uteroplacental perfusion;   Fetal growth;   Maternal and fetal safety
15 Not yet recruiting Blood Flow and Vascular Function in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Acute (1 hour) Sildenafil;   Drug: Sub-Chronic (4 weeks) Sildenafil;   Drug: Placebo
Outcome Measures: Exercise Capacity;   Flow-Mediated Dilation (FMD);   Arterial Stiffness Evaluation (PWV);   Physio Flow
16 Recruiting "As Required" Oral Sildenafil in Raynaud's Phenomenon
Condition: Raynaud's Phenomenon
Interventions: Drug: Sildenafil 40 mg;   Drug: Sildenafil 80 mg;   Drug: Placebo
Outcome Measures: Mean change in the Raynaud's Condition Score (RCS) during treatment, as compared to placebo.;   Frequency of RP: number of RP attacks during treatment, as compared to placebo.;   Patients' preference: comparison between the number of patients favoring a treatment to another.;   Pain associated with RP: Mean change in the Raynaud's pain score during treatment, as compared to placebo.;   Frequency and severity of adverse drug events during treatment, as compared to placebo;   Microvascular reactivity: index of skin perfusion in response to local/regional cooling after a single dose of sildenafil, as compared to placebo (laboratory experiments)
17 Recruiting Effectiveness of the Vasodilator Test With Revatio, Made in Patients With Acute Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Drug: Sildenafil 20mg oral vs Sildenafil 10mg intravenous
Outcome Measure: Effectiveness
18 Recruiting Sildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer
Condition: Kidney Tumor
Interventions: Drug: sildenafil citrate;   Other: placebo;   Procedure: therapeutic conventional surgery
Outcome Measures: Accrual rate;   Retention rate;   Participation rate;   Change in GFR;   Change in proteinuria;   Estimated blood loss;   Hemoglobin concentration;   Changes in blood pressure measurements;   Vasopressor support requirements during the operative procedure;   Intravenous fluid requirements during the operative procedure;   Overall complication rates;   Preliminary effect size of sildenafil citrate on change in GFR
19 Unknown  On Demand Versus Daily Sildenafil for Patients Undergoing Radical Prostatectomy
Condition: Erectile Dysfunction
Intervention: Drug: Sildenafil
Outcome Measures: Proportion of patients with an Erectile Function domain score of International Index of Erectile Function ( IIEF) => 22 at the end of the wash-out period (44 wks after surgery);   Proportion of patients with an Erectile Function domain score of IIEF => 22 at the end of the study (52 wks after surgery);   IIEF - Domain Scores for: Erection Hardness Score (1-4) Intercourse success rates defined by the Sexual Encounter Profile (SEP) questionnaire (questions 2 and 3) Safety Endpoints: Adverse event summarized Global assessment questions
20 Not yet recruiting Growth Hormone or Sildenafil as Therapies for Fatigue in Mild-​Traumatic-brain-injury (MTBI)
Condition: Traumatic Brain Injury
Interventions: Drug: Growth Hormone;   Drug: Sildenafil;   Drug: Placebo
Outcome Measures: Perceptual fatigue as measured weekly using the Brief Fatigue Inventory;   Performance fatigue as measured by using hand and leg dynamometry.